The Centers for Disease Control and Prevention (CDC) has implemented radical changes to the childhood immunization schedule. The agency has removed six vaccines from its routine recommendations—vaccinations that, over the last three decades, have been credited with preventing nearly 2 million hospitalizations and 90,000 deaths.
Vaccines against Hepatitis A, Hepatitis B, Rotavirus, Respiratory Syncytial Virus (RSV), Meningococcal disease, and Influenza/COVID-19 will henceforth be categorized under “shared clinical decision-making.” This implies that instead of a universal guideline, the responsibility shifts to parents, who must determine the appropriateness and associated risks of immunization during consultations with their physicians. However, for the general population, this shift creates a genuine risk of outbreaks of nearly forgotten diseases.
RSV is a leading cause of infant hospitalization, resulting in hundreds of fatalities annually; notably, 80% of severe complications occur in otherwise healthy children under two years of age. Significant progress has been recorded in other areas as well: Hepatitis A immunization has reduced disease prevalence by 90% since the 1990s. Regarding Hepatitis B, a 99% decrease in infections among children since 1990 has led to a reduction in liver cancer cases within the pediatric population.
Retrospectively, prior to 2006 (the large-scale implementation of the vaccination program), annual hospitalizations due to Rotavirus infection reached 70,000 cases. The disease, known as “winter vomiting disease,” caused an average of 50 fatalities per year. Epidemiological risks for Meningococcal disease are similarly critical: the disease is characterized by high lethality (10% of cases), while 20% of survivors suffer permanent, irreversible neurological or physical disabilities.
Although insurance systems fully cover vaccination costs, the CDC has retained only 11 basic vaccines on the mandatory immunization list (including MMR, DTaP, Polio, Varicella, and HPV). The U.S. Department of Health and Human Services (HHS) justifies this strategic change through “scientific revision” and the adaptation of the “Danish model.” However, statistics show that the annual hospitalization rate for Rotavirus in Denmark (1,200 cases) proportionally matches the pre-vaccination epidemiological data of the United States.
Serious concern is growing within the medical community regarding potential misunderstandings arising from the new regulations. There is a risk that parents may misinterpret the term “optional” as “less safe,” despite each vaccine having passed rigorous FDA safety controls. “Any kind of confusion in receiving information will directly translate to an increase in pediatric morbidity,” notes pediatrician Erik Ball.
Paul Offit, one of the co-creators of the Rotavirus vaccine, has strongly criticized the transition to the Danish model: “They tolerate 1,200 children being hospitalized a year… for us, that is unacceptable.” Experts point out that until now, the principle of “shared clinical decision-making” was used only in narrow, specific cases, and not for mass prevention in healthy infants against aggressive pathogens like RSV or Rotavirus.
HHS explains this decision as a desire to reduce vaccine skepticism, which they claim is caused by an “overburdened” immunization schedule. Nevertheless, it remains a fact that every vaccine removed from the list successfully passed rigorous FDA clinical testing.
From a legal perspective, state-level legislation remains unchanged at this stage. Legal experts believe that pediatricians will continue to be guided by the principles of evidence-based medicine, as professional standards and deontology mandate that they protect the patient’s best interests, regardless of transformations in federal directives.
Source: npr
